Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Psychopharmacology|December 11, 1999
Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeysJ Fernández-Ruiz, D Doudet, T G AignerPsychopharmacology|January 1, 1988
Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeysT G AignerCurrent Opinion in Neurobiology|April 1, 1995
Pharmacology of memory: cholinergic-glutamatergic interactionsT G AignerPsychopharmacology|January 1, 1988
Improved recognition memory in monkeys following naloxone administrationT G Aigner, M MishkinNeuroreport|January 31, 1996
Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeysN Matsuoka, T G AignerThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmineN Matsuoka, T G AignerBehavioral and Neural Biology|January 1, 1986
The effects of physostigmine and scopolamine on recognition memory in monkeysT G Aigner, M MishkinBehavioural Brain Research|April 30, 1993
Scopolamine impairs recall of one-trial stimulus-reward association in monkeysT G Aigner, M MishkinThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeysN Matsuoka, T G AignerBrain Research|August 26, 1996
The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeysN Matsuoka, T G AignerPageof 16